PRF-Technologies Ltd Information

PainReform is a diversified innovation company advancing specialty pharmaceutical therapies and AI-driven energy analytics. Its pharmaceutical programs focus on reformulation and sustained-release drug-delivery technologies designed to improve patient outcomes while reducing reliance on opioids and complex dosing regimens. Our strategy is to incorporate generic drugs which have been proven safe and effective with our proprietary extended drug-delivery system in order to create a significant improvement in therapy via extended-release drug products and to take advantage of the shorter 505(b)(2) regulatory pathway created by the U.S. Food and Drug Administration (“FDA”).